Ore. Federal Judge Grants Novartis Summary Judgment in Aredia/Zometa ONJ Case

PORTLAND, Ore. — An Oregon federal judge has granted Novartis Pharmaceuticals Corp. summary judgment in an Aredia/Zometa injury case, finding the plaintiff failed to establish a genuine dispute of material fact as to whether any alleged deficiency in the drugs’ warnings was the proximate cause of injuries sustained by a woman suffering from breast cancer at the time she was prescribed the drug.

In a March 20 order, Judge Anna J. Brown of the U.S. District Court for the District of Oregon explained that the deceased’s prescribing doctor testified that the warnings made him aware of the drugs’ risks, yet …